Cash flows from operating activities: | |
Net loss | -38.26M |
Adjustments to reconcile net loss to net cash used in operating activities: | |
Share-based compensation | 2.53M |
Loss from equity investment | |
Accretion of redeemable preferred stock of subsidiary | |
Interest receivable on loan to affiliate | |
Loss on derivatives | |
Depreciation | 3.58M |
Amortization of bond premium and interest expense | 2.19M |
Provision for doubtful accounts | |
Decrease (increase) in operating assets: | |
Accounts receivable | 26.59M |
Inventories | -12.45M |
Other assets | 108K |
Increase (decrease) in operating liabilities: | |
Accounts payable | -196K |
Accrued liabilities | -145K |
Deferred revenue | -15.33M |
Net cash used in operating activities | -46.51M |
Cash flows from investing activities: | |
Capital expenditures | -3.96M |
Convertible loan to affiliate | |
Treasury notes matured | |
Treasury notes purchased | |
Net cash provided by (used in) investing activities | -10.47M |
Cash flows from financing activities: | |
Repayment of debt | -9.55M |
Proceeds from revolving line of credit, net | |
Payment of preferred dividends and return of capital | -3.13M |
Proceeds from sale of common stock, net of registration fees | 68.79M |
Common stock issued for stock plans and related expenses | |
Net cash provided by financing activities | 92.3M |
Effects on cash from changes in foreign currency rates | -26K |
Net increase (decrease) in cash and cash equivalents | 35.3M |
Cash and cash equivalents-beginning of period | 58.85M |
Cash and cash equivalents-end of period | 94.15M |
Supplemental cash flow disclosures: | |
Cash interest paid | 1.3M |
Noncash financing and investing activity: | |
Common stock issued in settlement of prior year bonus obligation | |
Common stock issued for Employee Stock Purchase Plan in settlement of prior year accrued employee contributions | 105K |
Adjustment for modification of redeemable preferred stock of subsidiary |